A randomized, placebo-controlled, crossover, ascending dose tolerance and pharmacokinetic study of CVT-3146: A novel agent for potential use in myocardial perfusion imaging.
被引:4
作者:
Cannon, RO
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Cannon, RO
[1
]
Freestone, S
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Freestone, S
[1
]
Mair, SJ
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Mair, SJ
[1
]
Jerling, M
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Jerling, M
[1
]
Skettino, SL
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Skettino, SL
[1
]
Bellardinelli, L
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Bellardinelli, L
[1
]
Wolff, AA
论文数: 0引用数: 0
h-index: 0
机构:
CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USACVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA
Wolff, AA
[1
]
机构:
[1] CVT Therapeut Inc, Inveresk Res, Palo Alto, CA USA